Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin

PHASE3CompletedINTERVENTIONAL
Enrollment

423

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Hyperlipidemia
Interventions
DRUG

Fenofibrate/Simvastatin

Combination of Fenofibrate and Simvastatin 20mg

DRUG

Fenofibrate/Simvastatin

Combination of Fenofibrate and Simvastatin 40 mg

DRUG

Pravastatin

Pravastatin 40 mg

Trial Locations (41)

Unknown

Site 40, Athens

Site 39, Ioannina

Site 41, Thessaloniki

Site 37, Beer Yaakov

Site 19, Haifa

Site 22, Holon

Site 18, Jerusalem

Site 38, Kfar Saba

Site 17, Ramat Gan

Site 21, Ramat Gan

Site 20, Rehovot

Site 24, Safed

Site 23, Tel Aviv

Site 5, Arad

Site 7, Bacau

Site 1, Bucharest

Site 6, Cluj-Napoca

Site 4, Oradea

Site 3, Ploieşti

Site 2, Târgu Mureş

Site 27, Barnaul

Site 31, Kemerovo

Site 32, Krasnoyarsk

Site 25, Moscow

Site 28, Novosibirsk

Site 29, Saint Petersburg

Site 26, Smolensk

Site 30, Voronezh

Site 10, Alberton

Site 9, Bloemfontein

Site 14, Cape Town

Site 35, Durban

Site 36, eMkhomazi

Site 33, Hillcrest

Site 34, Kempton Park

Site 16, Komatipoort

Site 13, Krugersdorp

Site 11, Parow

Site 12, Port Elizabeth

Site 8, Pretoria

Site 15, Worcester

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00362206 - Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin | Biotech Hunter | Biotech Hunter